The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2025

Filed:

Jul. 24, 2019
Applicant:

Altergon S.a., Lugano, CH;

Inventors:

Assunta Borzacchiello, Naples, IT;

Maurizio Pagliuca, Lugano, CH;

Nicola Solimando, Lugano, CH;

Luigi Nicolais, Ercolano, IT;

Assignee:

ALTERGON S.A., Lugano, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 27/26 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/407 (2006.01); A61K 31/421 (2006.01); A61K 31/4365 (2006.01); A61K 31/4706 (2006.01); A61K 31/496 (2006.01); A61K 31/5415 (2006.01); A61K 31/60 (2006.01); A61K 31/616 (2006.01); A61K 47/22 (2006.01); A61K 47/36 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
A61L 27/26 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/407 (2013.01); A61K 31/421 (2013.01); A61K 31/4365 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/5415 (2013.01); A61K 31/60 (2013.01); A61K 31/616 (2013.01); A61K 47/22 (2013.01); A61K 47/36 (2013.01); A61K 47/40 (2013.01); A61L 2300/21 (2013.01); A61L 2300/216 (2013.01); A61L 2300/232 (2013.01); A61L 2300/236 (2013.01); A61L 2300/41 (2013.01);
Abstract

The present invention relates to compositions based on: (a) a glycosaminoglycan or mixtures thereof; (b) one or more tocopherols, tocotrienols and mixtures thereof; and (c) a selected stabilizer. The composition is a solution, with the agents not chemically bound with each other. The component (a) can be hyaluronic acid (HA) or a salt thereof; the component (b) can be a polyether clathrate a cyclodextrin, or a combination of a fatty acid with an emulsifier; the component (c) can be α-tocopherols, β-tocopherols, γ-tocopherols, δ-tocopherols; α-tocotrienols, β-tocotrienols, γ-tocotrienols, δ-tocotrienols. Preferably component (c) is vitamin E. The agents strongly cooperate to provide enhanced and more stable viscoelastic properties, resulting in a product with higher resistance to thermal treatments like e.g. heat-sterilization, autoclaving, etc. The present compositions, optionally loaded with pharmaceutically and/or cosmetically active agents, are advantageously used in medical or cosmetic methods.


Find Patent Forward Citations

Loading…